共 2 条
[1]
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine. Stanley,WC,Marzilli,M. Fundamental and Clinical Pharmacology . 2003
[2]
The antianginal drug trimetazidine shifts cardiac energy metabolism form fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Kantor PF, Lucien A, Kozak R, et al. Cire Research . 2000